Targeting PDE4 with topical drugs has been unsuccessful due to the difficulty in crossing the epidermis. A novel formulation of roflumilast facilitates drug delivery to the inflammatory cells of psoriasis. We worked with Arcutis scientists & devised a visual model of roflumilast emulsions. Features: lipid matrix, skin cells, epidermis, dermis, corneocytes, stratum corneum, pharma MOA, pharmaceutical MOA animation, drug MOA, dermatology, plaque psoriasis, pharmacology.
Keywords: Animation, 3D, Advertising / Marketing, Product Demonstration, Professional Education, Allergy / Immunology, Dermatology, Disease Management, Pharmacology, Mechanism of Action (MOA)
Arcutis Biotherapeutic